Research in brain tumours

Cancer research is a long and careful process. It often takes many years for tests and treatments that researchers are studying to be ready for use in people with cancer.

Most research starts in a lab (laboratory) where researchers will test ideas, procedures or treatments in cells or animals. If lab researchers find promising ways to treat, manage or prevent cancer, these need to be tested in people (called clinical research). All research is an important part of learning and improving cancer care, even if it’s not studied in people.

As research is done, the results are published in scientific or medical journals and presented at conferences around the world – adding to our collective knowledge of cancer. Doctors use what they learn from research studies to offer the most effective treatments and screening methods for cancer.

We are always learning more about cancer. The following is some promising research in brain tumours.

Expert review and references

  • James Perry, MD, FRCPC
  • Czyzewski W, Kus-Budzynska K, Sobstyl J, Sojka M, Litak J, Szalinski T, et al. CAR-T cell therapy for glioblastoma: advances, challenges, and future directions. Annals of Medicine and Surgery (London). 2025: 87(9):5743-5756.
  • Grassi I, Sansovini M, Matteucci F, Marini I, Caroli P, Celli M, et al. Radioligand therapy for primary brain tumors: a PRISMA-based systematic review of meningiomas and gliomas. Frontiers in Medicine (Lausanne). 2025: 12:1728797.
  • Izha M, Ahmad Z, Moazzam M, Jader A. Targeted liquid biopsy for brain tumours. Journal of Liquid Biopsy. 2024: 6:100170.
  • Rath S, Shafeea MS, Hussein AFA, Hashim AS, Hassanaien S, Pastrana-Bandes S, Chaurasia B. CAR-T-cell therapy in meningioma: current investigations, advancements and insight into future directions. Annals of Medicine and Surgery (London). 2024: 86(10):5957-5965.
  • Rossi J, Picca A, Santonocito OS, Schembari S, Testaverde L, Sanson M, et al. Advances in the management of patients with IDH_mutant glioma. The Oncologist. 2025: 30(12):oyaf391.
  • Seyhan AA. Circulating liquid biopsy biomarkers in glioblastoma: Advances and challenges. International Journal of Molecular Sciences. 2024: 25(14):7974.
  • Ter Linden E, Abels ER, van Solinge TS, Neefjes J, Broekman MLD. Overcoming barriers in glioblastoma- advances in drug delivery systems. Cells. 13(12):998.
  • Wireko AA, Sha MH, Tan JK, Ranganathan S, Sanker V, et al. Immunotherapeutic advances in glioma management: The rise of vaccine-based approaches. CNS Neurosciences & Therapeutics. 2024: 30(9):e70013.

Your trusted source for accurate cancer information

With support from readers like you, we can continue to provide the highest quality cancer information for over 100 types of cancer.

We’re here to ensure easy access to accurate cancer information for you and the millions of people who visit this website every year. But we can’t do it alone.

Every donation helps fund reliable cancer information, compassionate support services and the most promising research. Please give today because every contribution counts. Thank you.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2026 Canadian Cancer Society